Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $13.0455.
Several analysts recently weighed in on the company. The Goldman Sachs Group restated a “neutral” rating and set a $13.00 target price on shares of Ardent Health in a research note on Thursday, August 6th. Truist Financial upped their price target on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Weiss Ratings cut Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Zacks Research downgraded shares of Ardent Health from a “hold” rating to a “strong sell” rating in a research note on Thursday, August 6th. Finally, Guggenheim boosted their target price on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th.
Read Our Latest Stock Analysis on Ardent Health
Ardent Health Stock Down 0.3%
Ardent Health (NYSE:ARDT – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, analysts forecast that Ardent Health will post 0.96 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd raised its position in shares of Ardent Health by 1,177.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after buying an additional 2,638 shares during the last quarter. Allworth Financial LP acquired a new stake in Ardent Health during the second quarter worth about $28,000. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Ardent Health during the third quarter worth about $61,000. Monetary Solutions Ltd bought a new position in Ardent Health during the fourth quarter valued at about $79,000. Finally, New York State Common Retirement Fund increased its stake in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares during the period.
About Ardent Health
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
See Also
- Five stocks we like better than Ardent Health
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
